A phase 1 study of MM-141, a novel tetravalent monoclonal antibody targeting IGF-1R and ErbB3, in relapsed or refractory solid tumors
Authors:
- S. IsakoffSIS. Isakoff
- R. BahledaRBR. Bahleda
- M. SalehMSM. Saleh
- R. BordoniRBR. Bordoni
- A. ShieldsASA. Shields
- J. DauerJDJ. Dauer
- M. CurleyMCM. Curley
- J. BaumJBJ. Baum
- T. McClureTMT. McClure
- C.U. LouisCLC.U. Louis
- J.C. SoriaJSJ.C. Soria
- 1 December 2016
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 69, S137-S138